Tongfeng Zhao

481 total citations
25 papers, 383 citations indexed

About

Tongfeng Zhao is a scholar working on Molecular Biology, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Tongfeng Zhao has authored 25 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Nephrology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Tongfeng Zhao's work include Chronic Kidney Disease and Diabetes (5 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Mitochondrial Function and Pathology (3 papers). Tongfeng Zhao is often cited by papers focused on Chronic Kidney Disease and Diabetes (5 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Mitochondrial Function and Pathology (3 papers). Tongfeng Zhao collaborates with scholars based in China. Tongfeng Zhao's co-authors include Lingxiao Zhang, Jing Lv, Yuanyuan Luo, Xiao Huang, Xiaodan Zhang, Xiaohong Xu, Huanliang Liu, Wan‐Xi Yang, Yuanyuan Luo and Wenli Hu and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cell Death and Differentiation and Atherosclerosis.

In The Last Decade

Tongfeng Zhao

24 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tongfeng Zhao China 13 187 75 72 61 61 25 383
Panwei Mu China 12 177 0.9× 71 0.9× 165 2.3× 78 1.3× 30 0.5× 24 449
Xiaofei Feng China 12 218 1.2× 59 0.8× 22 0.3× 50 0.8× 71 1.2× 31 458
Yunpeng Chang China 10 300 1.6× 39 0.5× 110 1.5× 122 2.0× 93 1.5× 14 647
Dajun Chai China 12 208 1.1× 43 0.6× 64 0.9× 44 0.7× 33 0.5× 32 423
Atsuko Tomizawa Japan 8 173 0.9× 107 1.4× 43 0.6× 178 2.9× 41 0.7× 9 430
Biao Xu China 11 201 1.1× 75 1.0× 50 0.7× 47 0.8× 39 0.6× 17 445
Yun Ti China 14 202 1.1× 70 0.9× 66 0.9× 92 1.5× 49 0.8× 45 564
Por J. Huang Taiwan 6 151 0.8× 78 1.0× 34 0.5× 32 0.5× 32 0.5× 8 412
Mingfeng Cao China 12 134 0.7× 74 1.0× 59 0.8× 116 1.9× 38 0.6× 21 353
Satoru Noji Japan 5 233 1.2× 97 1.3× 65 0.9× 51 0.8× 36 0.6× 6 353

Countries citing papers authored by Tongfeng Zhao

Since Specialization
Citations

This map shows the geographic impact of Tongfeng Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tongfeng Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tongfeng Zhao more than expected).

Fields of papers citing papers by Tongfeng Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tongfeng Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tongfeng Zhao. The network helps show where Tongfeng Zhao may publish in the future.

Co-authorship network of co-authors of Tongfeng Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Tongfeng Zhao. A scholar is included among the top collaborators of Tongfeng Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tongfeng Zhao. Tongfeng Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Xiaofei, et al.. (2025). Association between the serum Klotho levels and diabetic kidney disease: results from the NHANES 2007–2016 and Mendelian randomization study. Journal of Diabetes & Metabolic Disorders. 24(2). 156–156. 1 indexed citations
2.
Su, Ning, et al.. (2024). YME1L-mediated mitophagy protects renal tubular cells against cellular senescence under diabetic conditions. Biological Research. 57(1). 10–10. 10 indexed citations
3.
Luo, Yuanyuan, Lingxiao Zhang, & Tongfeng Zhao. (2023). Identification and analysis of cellular senescence-associated signatures in diabetic kidney disease by integrated bioinformatics analysis and machine learning. Frontiers in Endocrinology. 14. 1193228–1193228. 17 indexed citations
4.
Luo, Yuanyuan, et al.. (2023). TRAP1 inhibits MARCH5-mediated MIC60 degradation to alleviate mitochondrial dysfunction and apoptosis of cardiomyocytes under diabetic conditions. Cell Death and Differentiation. 30(10). 2336–2350. 11 indexed citations
5.
Liu, Hailing, et al.. (2022). Smoking Is a Risk Factor of Colorectal Advanced Adenomas Compared to Nonadvanced Adenomas. Open Journal of Gastroenterology. 12(10). 278–285.
6.
Su, Ning, et al.. (2021). TRAP1 inhibits MIC60 ubiquitination to mitigate the injury of cardiomyocytes and protect mitochondria in extracellular acidosis. Cell Death Discovery. 7(1). 389–389. 9 indexed citations
7.
Li, Xia, Lingxiao Zhang, Jing Lv, et al.. (2019). Neuroprotective effects of an Nrf2 agonist on high glucose-induced damage in HT22 cells. Biological Research. 52(1). 53–53. 27 indexed citations
8.
Gu, Zhenyang, et al.. (2013). A Case of Primary Hyperparathyroidism due to Ectopic Parathyroid Adenoma in the Thymus, Accompanied With Vitamin D Deficiency. The Journal of Clinical Endocrinology & Metabolism. 98(6). 2218–2222. 2 indexed citations
9.
Xu, Xiaohong, et al.. (2012). Cardioprotective Effect of Sodium Ferulate in Diabetic Rats. International Journal of Medical Sciences. 9(4). 291–300. 29 indexed citations
10.
Zhao, Tongfeng, et al.. (2011). Expression of Human Globular Adiponectin-Glucagon-Like Peptide-1 Analog Fusion Protein and Its Assay of Glucose-Lowering Effect In Vivo. International Journal of Medical Sciences. 8(3). 203–209. 4 indexed citations
11.
Zhao, Tongfeng, et al.. (2010). Meta-analysis on the effect of the Ala54Thr polymorphism of the fatty acid-binding protein 2 gene on body mass index. Nutrition Metabolism and Cardiovascular Diseases. 21(10). 823–829. 8 indexed citations
12.
Huang, Xiao, et al.. (2010). Effects of peroxisome proliferator activated receptor-gamma 2 gene Pro12Ala polymorphism on fasting blood lipids: A meta-analysis. Atherosclerosis. 215(1). 136–144. 20 indexed citations
13.
Zhao, Tongfeng, et al.. (2010). Genetic effects of adiponectin on blood lipids and blood pressure. Clinical Endocrinology. 74(2). 214–222. 26 indexed citations
14.
Zhao, Tongfeng, et al.. (2010). Association of the apolipoprotein A5 gene -1131 T>C polymorphism with fasting blood lipids: a meta-analysis in 37859 subjects. BMC Medical Genetics. 11(1). 120–120. 24 indexed citations
15.
Zhao, Tongfeng, et al.. (2010). Association of the fatty acid‐binding protein 2 gene Ala54Thr polymorphism with insulin resistance and blood glucose: a meta‐analysis in 13451 subjects. Diabetes/Metabolism Research and Reviews. 26(5). 357–364. 15 indexed citations
16.
Zhao, Tongfeng, et al.. (2009). Ala54Thr polymorphism of fatty acid-binding protein 2 gene and fasting blood lipids: A meta-analysis. Atherosclerosis. 210(2). 461–467. 24 indexed citations
17.
Zhao, Tongfeng, et al.. (2009). Hypoxia-inducible factor-1α gene polymorphisms and cancer risk: a meta-analysis. Journal of Experimental & Clinical Cancer Research. 28(1). 159–159. 49 indexed citations
18.
Qin, Qiaojing, et al.. (2008). [Study on the effect and mechanism of ascorbic acid on renal podocytes in diabetes].. PubMed. 24(1). 112–5. 3 indexed citations
19.
Zhao, Tongfeng, et al.. (2004). [Renal protective effect and its mechanism of sodium ferulate in diabetic rats].. PubMed. 24(5). 445–9. 3 indexed citations
20.
Zhao, Tongfeng. (2001). The effects of sodium ferulate on early diabetic nephropathy. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Panwei Mu Breakdown of academic impact, for papers by Xiaofei Feng Breakdown of academic impact, for papers by Yunpeng Chang Breakdown of academic impact, for papers by Dajun Chai Breakdown of academic impact, for papers by Atsuko Tomizawa Breakdown of academic impact, for papers by Biao Xu Breakdown of academic impact, for papers by Yun Ti Breakdown of academic impact, for papers by Por J. Huang Breakdown of academic impact, for papers by Mingfeng Cao Breakdown of academic impact, for papers by Satoru Noji
Rankless by CCL
2026